These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
95 related items for PubMed ID: 20196407
1. Comparison of efficacy between 1 mg overnight dexamethasone suppression test and 2-day low dose dexamethasone suppression test for diagnosis of Cushing's syndrome. Kungpanichkul N. J Med Assoc Thai; 2010 Jan; 93(1):27-33. PubMed ID: 20196407 [Abstract] [Full Text] [Related]
2. Nocturnal 8 mg dexamethasone suppression test: a practical and accurate test for identification of the cause of endogenous Cushing's syndrome. Sriussadaporn S, Ploybutr S, Peerapatdit T, Plengvidhya N, Nitiyanant W, Vannasaeng S, Vichayanrat A. Br J Clin Pract; 1996 Jan; 50(1):9-13. PubMed ID: 8729595 [Abstract] [Full Text] [Related]
3. An update on the overnight dexamethasone suppression test for the diagnosis of Cushing's syndrome: limitations in patients with mild and/or episodic hypercortisolism. Friedman TC. Exp Clin Endocrinol Diabetes; 2006 Jul; 114(7):356-60. PubMed ID: 16915537 [Abstract] [Full Text] [Related]
4. Overnight dexamethasone suppression test: a reliable screen for Cushing's syndrome in the obese. Ness-Abramof R, Nabriski D, Apovian CM, Niven M, Weiss E, Shapiro MS, Shenkman L. Obes Res; 2002 Dec; 10(12):1217-21. PubMed ID: 12490665 [Abstract] [Full Text] [Related]
5. A dose-response study of salivary cortisol after dexamethasone suppression test in Cushing's disease and its potential use in the differential diagnosis of Cushing's syndrome. Castro M, Elias LL, Elias PC, Moreira AC. Clin Endocrinol (Oxf); 2003 Dec; 59(6):800-5. PubMed ID: 14974925 [Abstract] [Full Text] [Related]
6. The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing's syndrome from pseudo-Cushing's states. Pecori Giraldi F, Pivonello R, Ambrogio AG, De Martino MC, De Martin M, Scacchi M, Colao A, Toja PM, Lombardi G, Cavagnini F. Clin Endocrinol (Oxf); 2007 Feb; 66(2):251-7. PubMed ID: 17223996 [Abstract] [Full Text] [Related]
7. A comparison of the standard high dose dexamethasone suppression test and the overnight 8-mg dexamethasone suppression test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome. Dichek HL, Nieman LK, Oldfield EH, Pass HI, Malley JD, Cutler GB. J Clin Endocrinol Metab; 1994 Feb; 78(2):418-22. PubMed ID: 8106630 [Abstract] [Full Text] [Related]
8. Overnight dexamethasone suppression test in the diagnosis of Cushing's disease. Esfahanian F, Kazemi R. Acta Med Iran; 2010 Feb; 48(4):222-5. PubMed ID: 21279933 [Abstract] [Full Text] [Related]
9. The low-dose dexamethasone suppression test: a reevaluation in patients with Cushing's syndrome. Findling JW, Raff H, Aron DC. J Clin Endocrinol Metab; 2004 Mar; 89(3):1222-6. PubMed ID: 15001614 [Abstract] [Full Text] [Related]
10. [Comparing overnight dexamethasone suppression test, urine free cortisol, and midnight serum cortisol for the initial diagnosis of Cushing' s syndrome]. Tang TJ, Liu YP, Yu YR. Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 44(5):764-8. PubMed ID: 24325108 [Abstract] [Full Text] [Related]
11. Evaluation of endocrine tests. B: screening for hypercortisolism. Holleman F, Endert E, Prummel MF, van Vessem-Timmermans M, Wiersinga WM, Fliers E. Neth J Med; 2005 Oct; 63(9):348-53. PubMed ID: 16244382 [Abstract] [Full Text] [Related]
12. [Investigation of Cushing's syndrome. The diagnostic value of the dexamethasone suppression test, the metopirone test and the CRF test]. Johannesen O, Jørgensen H, Frey H, Norman N. Tidsskr Nor Laegeforen; 1989 Sep 20; 109(26):2678-82. PubMed ID: 2554527 [Abstract] [Full Text] [Related]
13. [Overnight dexamethasone suppression test in the screening of Cushing's syndrome]. Pikkarainen L, Sane T. Duodecim; 1996 Sep 20; 112(7):598-603. PubMed ID: 10592624 [No Abstract] [Full Text] [Related]
14. Comparison of the dexamethasone-suppressed corticotropin-releasing hormone test and low-dose dexamethasone suppression test in the diagnosis of Cushing's syndrome. Martin NM, Dhillo WS, Banerjee A, Abdulali A, Jayasena CN, Donaldson M, Todd JF, Meeran K. J Clin Endocrinol Metab; 2006 Jul 20; 91(7):2582-6. PubMed ID: 16670165 [Abstract] [Full Text] [Related]
15. Specificity of first-line tests for the diagnosis of Cushing's syndrome: assessment in a large series. Pecori Giraldi F, Ambrogio AG, De Martin M, Fatti LM, Scacchi M, Cavagnini F. J Clin Endocrinol Metab; 2007 Nov 20; 92(11):4123-9. PubMed ID: 17698908 [Abstract] [Full Text] [Related]
16. [Night suppression with high doses of dexamethasone and metyrapone tests for the etiological diagnosis of Cushing syndrome]. Rossi MA, Chervin RA, Bruno OD. Medicina (B Aires); 1996 Nov 20; 56(5 Pt 1):455-62. PubMed ID: 9239880 [Abstract] [Full Text] [Related]
17. Diagnostic tests for children who are referred for the investigation of Cushing syndrome. Batista DL, Riar J, Keil M, Stratakis CA. Pediatrics; 2007 Sep 20; 120(3):e575-86. PubMed ID: 17698579 [Abstract] [Full Text] [Related]
18. Comparison of 1 mg and 2 mg overnight dexamethasone suppression tests for the screening of Cushing's syndrome in obese patients. Sahin M, Kebapcilar L, Taslipinar A, Azal O, Ozgurtas T, Corakci A, Akgul EO, Taslipinar MY, Yazici M, Kutlu M. Intern Med; 2009 Sep 20; 48(1):33-9. PubMed ID: 19122354 [Abstract] [Full Text] [Related]
20. Dynamic pituitary MRI has high sensitivity and specificity for the diagnosis of mild Cushing's syndrome and should be part of the initial workup. Friedman TC, Zuckerbraun E, Lee ML, Kabil MS, Shahinian H. Horm Metab Res; 2007 Jun 20; 39(6):451-6. PubMed ID: 17578763 [Abstract] [Full Text] [Related] Page: [Next] [New Search]